Low serum diamine oxidase (DAO) activity levels in patients with migraine. 2018

Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
Department of Neurology, Hospital General de Catalunya, C/ Pere i Pons 1, 08915, Sant Cugat del Vallès, Spain.

Histamine intolerance is a disorder in the homeostasis of histamine due to a reduced intestinal degradation of this amine, mainly caused by a deficiency in the enzyme diamine oxidase (DAO). Among the several multi-faced symptoms associated with histamine intolerance, headache is one of the most recognized and disabling consequences. The aim of this study was to determine the prevalence of DAO deficiency in patients with a confirmed migraine diagnosis according to the current International Headache Society (IHS) and in non-migraine subjects. DAO activity was assessed in a total of 198 volunteers recruited at the Headache Unit of the Hospital General de Catalunya, 137 in the migraine group and 61 as a control group. DAO enzyme activity in blood samples was determined by ELISA test. Values below 80 HDU/ml (Histamine Degrading Unit/ml) were considered as DAO deficient. Mean value of DAO activity from migraine population (64.5 ± 33.5 HDU/ml) was significantly lower (p < 0.0001) than that obtained from healthy volunteers (91.9 ± 44.3 HDU/ml). DAO deficiency was more prevalent in migraine patients than in the control group. A high incidence rate of DAO deficiency (87%) was observed in the group of patients with migraine. On the other hand, 44% of non-migranous subjects had levels of DAO activity lower than 80 HDU/ml. Despite the multifactorial aetiology of migraine, these results seem to indicate that this enzymatic deficit could be related to the onset of migraine.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008881 Migraine Disorders A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) Acute Confusional Migraine,Headache, Migraine,Status Migrainosus,Abdominal Migraine,Cervical Migraine Syndrome,Hemicrania Migraine,Migraine,Migraine Headache,Migraine Variant,Sick Headache,Abdominal Migraines,Acute Confusional Migraines,Cervical Migraine Syndromes,Disorder, Migraine,Disorders, Migraine,Headache, Sick,Headaches, Migraine,Headaches, Sick,Hemicrania Migraines,Migraine Disorder,Migraine Headaches,Migraine Syndrome, Cervical,Migraine Syndromes, Cervical,Migraine Variants,Migraine, Abdominal,Migraine, Acute Confusional,Migraine, Hemicrania,Migraines,Migraines, Abdominal,Migraines, Acute Confusional,Migraines, Hemicrania,Sick Headaches,Variant, Migraine,Variants, Migraine
D010044 Outpatient Clinics, Hospital Organized services in a hospital which provide medical care on an outpatient basis. Ambulatory Care Facilities, Hospital,Hospital Outpatient Clinics,Clinic, Hospital Outpatient,Clinics, Hospital Outpatient,Hospital Outpatient Clinic,Outpatient Clinic, Hospital
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006631 Amine Oxidase (Copper-Containing) A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. Diamine Oxidase,Histaminase,Amine Oxidase, Copper-Containing,Copper Amine Oxidase,Diaminobenzidine Oxidase,Semicarbazide-Sensitive Amine Oxidase,Xylylene Diamine Oxidase,Amine Oxidase, Copper,Amine Oxidase, Copper Containing,Amine Oxidase, Semicarbazide-Sensitive,Copper-Containing Amine Oxidase,Diamine Oxidase, Xylylene,Oxidase, Copper Amine,Oxidase, Copper-Containing Amine,Oxidase, Diamine,Oxidase, Diaminobenzidine,Oxidase, Semicarbazide-Sensitive Amine,Oxidase, Xylylene Diamine,Semicarbazide Sensitive Amine Oxidase
D006786 Hospitals, Urban Hospitals located in metropolitan areas. City Hospitals,Hospitals, City,Hospitals, City, Non-Public-Owned,Hospitals, Metropolitan,Urban Hospitals,City Hospitals, Non-Public-Owned,Metropolitan Hospitals,Non-Public-Owned City Hospitals,City Hospital,City Hospital, Non-Public-Owned,City Hospitals, Non Public Owned,Hospital, City,Hospital, Metropolitan,Hospital, Non-Public-Owned City,Hospital, Urban,Hospitals, Non-Public-Owned City,Metropolitan Hospital,Non Public Owned City Hospitals,Non-Public-Owned City Hospital,Urban Hospital
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
June 2022, European journal of clinical investigation,
Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
May 1989, Hinyokika kiyo. Acta urologica Japonica,
Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
September 1989, Digestive diseases and sciences,
Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
November 1984, Digestive diseases and sciences,
Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
January 1989, The International journal of biological markers,
Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
March 1959, Acta physiologica Scandinavica,
Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
May 2024, European journal of clinical nutrition,
Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
March 2016, International journal of immunopathology and pharmacology,
Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
April 1986, Agents and actions,
Joan Izquierdo-Casas, and Oriol Comas-Basté, and M Luz Latorre-Moratalla, and Marian Lorente-Gascón, and Adriana Duelo, and M Carmen Vidal-Carou, and Luis Soler-Singla
October 1985, Agents and actions,
Copied contents to your clipboard!